CHEST 2015 will feature original chest medicine investigative research from around the world, case-based learning sessions that offer solutions to real-world clinical problems, and in-depth presentations and information that can be applied to advance patient care in daily practice.
Q&A With Barbara A. Phillips From University of Kentucky: CHEST Takes Educating Doctors To Global Levels
Q&A With Danny McBryan From Boehringer Ingelheim: New Data Shows COPD Medication Could Help Asthma Patients Better Manage Symptoms
Q&A With Danny McBryan From Boehringer Ingelheim: Patients With IPF Have First Signs of Hope With Approval of New Medication
Q&A With Alex Niven From University of Washington: As Healthcare Changes Interdisciplinary Approaches Become More Valuable to Doctors And Patients
Q&A With Jad Kebbe From University At Buffalo: Looking At the Impact of PTSD On Intensive Care Patients
Millennials aren't the only ones using social media; professionals and the minds behind credible institutions have taken to the websites to spread their news and messages. A recent analysis that will be described at CHEST 2015 in MontrÃ©al, Canada found just how prominent Twitter discussions are at pulmonary conferences â€“ including CHEST over the years.
When the Food and Drug Administration Amendment Act (FDAAA) went into effect in 2007, summaries from clinical trials were required to be posted to ClinicalTrials.gov. While demographics are required in data, race/ethnicity are not, and an alarming amount of pulmonary studies did not report the optional information.